Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

An atypical caspase-independent death pathway for an immunogenic cancer cell line

Abstract

REGb cell line, a highly immunogenic tumor cell variant isolated from a rat colon cancer, yields regressive tumors when injected into syngeneic hosts. We previously demonstrated that REGb tumor immunogenicity was related to the capacity of releasing dead cells in vivo. Also, in vitro, REGb cell monolayers release dead cells, especially when cultured in serum-free medium. In the current study, we show that the release of dead cells results from an atypical death process associating features of necrosis and apoptosis. In spite of features considered as hallmarks of caspase-dependent apoptosis, including chromatin fragmentation and DNA oligonucleosomal cleavage, caspases are not activated and caspase inhibitors are ineffective to prevent REGb cell death. In contrast with a number of other types of cell death, the spontaneous death of REGb cells in culture depends on de novo protein synthesis as this death is blocked by low doses of the mRNA translation inhibitor cycloheximide. This unusual mode of cell death that associates necrotic and apoptotic features could provide optimal conditions for triggering a specific immune response.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  • Albert ML, Sauter B, Bhardwaj N . 1998 Nature 392: 86–89

  • Belmokhtar CA, Hillion J, Segal-Bendirdjian E . 2001 Oncogene 20: 3354–3362

  • Belmokhtar CA, Torriglia A, Counis MF, Courtois Y, Jacquemin-Sablon A, Segal-Bendirdjian E . 2000 Exp. Cell Res. 254: 99–109

  • Bonnotte B, Favre N, Moutet M, Fromentin A, Solary E, Martin M, Martin F . 1998 J. Immunol. 161: 1433–1438

  • Bonnotte B, Favre N, Moutet M, Fromentin A, Solary E, Martin M, Martin F . 2000 J. Immunol. 164: 1995–2000

  • Caignard A, Martin MS, Michel MF, Martin F . 1985 Int. J. Cancer 36: 273–279

  • Chen D, Stetler RA, Cao G, Pei W, O'Horo C, Yin XM, Chen J . 2000 J. Biol. Chem. 275: 38508–38517

  • Dumont C, Dürrbach A, Bidere N, Rouleau M, Kroemer G, Bernard G, Hirsch F, Charpentier B, Susin SA, Senik A . 2000 Blood 96: 1030–1038

  • Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J, Kroemer G . 2000 FASEB J. 14: 729–739

  • Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S . 1998 Nature 391: 43–50

  • Famulski KS, Macdonald D, Paterson MC, Sikora E . 1999 Cell Death Differ. 6: 281–289

  • Gallucci S, Lolkema M, Matzinger P . 1999 Nat. Med. 5: 1249–1255

  • Garcia Calvo M, Peterson EP, Rasper DM, Vaillancourt JP, Zamboni R, Nicholson DW, Thornberry NA . 1998 J. Biol. Chem. 273: 32608–32613

  • Lee ST, Hoeflich KP, Wasfy GW, Woodgett JR, Leber B, Andrew DW, Hedley DW, Penn LZ . 1999 Oncogene. 18: 3520–3528

  • Li LY, Luo X, Wang X . 2001 Nature 412: 95–99

  • Matzinger P . 1994 Ann. Rev. Immunol. 12: 991–1045

  • Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG . 1998 Nat. Med. 4: 581–587

  • Monney L, Otter I, Olivier R, Ozer HL, Haas AL, Omura S, Borner C . 1998 J. Biol. Chem. 273: 6121–6131

  • Rensing-Ehl A, Frei K, Flury R, Matiba B, Mariani SM, Weller M, Aebischer P, Krammer PH, Fontana A . 1995 Eur. J. Immunol. 25: 2253–2258

  • Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P, Rugarli C, Manfredi AA . 1998 J. Immunol. 161: 4467–4471

  • Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N . 2000 J. Exp. Med. 191: 423–434

  • Shaif-Muthana M, McIntyre C, Sisley K, Rennie I, Murray A . 2000 Cancer Res. 60: 6441–6447

  • Sperandio S, de Belle I, Bredesen DE . 2000 Proc. Natl. Acad. Sci. USA 97: 14376–14381

  • Torriglia A, Perani P, Brossas JY, Altairac S, Zeggai S, Martin E, Tréton J, Courtois Y, Counis MC . 2000 Ann. NY Acad. Sci. 926: 192–203

  • Voehringer DW, McConkey DJ, McDonnell TJ, Brisbay S, Meyn RE . 1998 Proc. Natl. Acad. Sci. USA 95: 2956–2960

Download references

Acknowledgements

We thank Alicia Torriglia (INSERM, U450) for discussions about acidic DNAses, Jeannine Lherminier (INRA Dijon) for excellent advice on electron microscopy, Sandeep Gurbuxani and François Ghiringhelli for help in discussing and revising the manuscript. This work was supported in part by a grant from the Association for Research on Cancer (ARC 51-29) and by help from the French National League against Cancer (Burgundy and Saône-et-Loire Committees). Guido Kroemer received grants from the French National League against Cancer.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernard Bonnotte.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Larmonier, N., Billerey, C., Rébé, C. et al. An atypical caspase-independent death pathway for an immunogenic cancer cell line. Oncogene 21, 6091–6100 (2002). https://doi.org/10.1038/sj.onc.1205738

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205738

Keywords

This article is cited by

Search

Quick links